Literature DB >> 7478516

Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.

D Rusciano1, P Lorenzoni, M M Burger.   

Abstract

The murine melanoma B16-LS9 cell line was obtained after repeated passages in vivo through the liver of syngeneic mice, and shows an enhanced ability to colonize the liver after intravenous inoculation when compared to its parental, unselected counterpart B16-F1. We have previously shown that paracrine growth effects mainly account for better growth of B16-LS9 in the liver than at other sites, and more recently we reported hepatic transferrin as a factor contributing to efficient growth in the liver. Here we show that increased expression of constitutively activated c-met (the receptor for Hepatocyte Growth Factor/Scatter Factor) consistently occurs during selection of B16 cells through the liver. Constitutive activation of c-met seems to follow its own overexpression and not to depend on an autocrine mechanism. As a consequence, liver-selected B16 melanoma cells have higher tyrosine-kinase activity and higher amounts of tyrosine-phosphorylated proteins than parental B16-F1 or lung-specific B16-F10 cells. Overexpression of constitutively activated c-met enhances motility and invasiveness of B16-LS9 cells, presumably favoring their colonization efficiency in vivo. However, whether levels of c-met expression also determine the organ-specificity of B16 melanoma cells needs further clarification.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478516

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

2.  Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).

Authors:  Jason J Luke; Daniel J Olson; Jacob B Allred; Carrie A Strand; Riyue Bao; Yuanyuan Zha; Timothy Carll; Brian W Labadie; Bruno R Bastos; Marcus O Butler; David Hogg; Pamela N Munster; Gary K Schwartz
Journal:  Clin Cancer Res       Date:  2019-09-26       Impact factor: 12.531

3.  Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor.

Authors:  R Wang; R Kobayashi; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

4.  Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway.

Authors:  M Jeffers; G A Taylor; K M Weidner; S Omura; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

5.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

6.  Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

Authors:  M J Hendrix; E A Seftor; R E Seftor; D A Kirschmann; L M Gardner; H C Boldt; M Meyer; J Pe'er; R Folberg
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

7.  Genetics and genomics of melanoma.

Authors:  Papia Ghosh; Lynda Chin
Journal:  Expert Rev Dermatol       Date:  2009-04-01

8.  c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.

Authors:  Maya Gordin; Melania Tesio; Sivan Cohen; Yael Gore; Frida Lantner; Lin Leng; Richard Bucala; Idit Shachar
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

9.  Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.

Authors:  Matthew H Herynk; Rachael Tsan; Robert Radinsky; Gary E Gallick
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

Authors:  Zhao-Shi Zeng; Martin R Weiser; Eleanor Kuntz; Chin-Tung Chen; Sajid A Khan; Ann Forslund; Garrett M Nash; Mark Gimbel; Yuka Yamaguchi; Alfred T Culliford; Matthew D'Alessio; Francis Barany; Philip B Paty
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.